Drug effectiveness in reducing glucocorticoid-induced bone loss: The drug denosumab was superior to a commonly used drug in a 12-month study enrolling 795 patients -- ScienceDaily

from bitly http://bit.ly/2vUv0ux
via IFTTT http://bit.ly/2vUv0uxhttps://monhebranco61.blogspot.co.uk/